Download the development of a mouse mutant for studying the role of nkg2d in

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

T cell wikipedia , lookup

Hygiene hypothesis wikipedia , lookup

Immune system wikipedia , lookup

Molecular mimicry wikipedia , lookup

Cancer immunotherapy wikipedia , lookup

Adaptive immune system wikipedia , lookup

Adoptive cell transfer wikipedia , lookup

Immunosuppressive drug wikipedia , lookup

Innate immune system wikipedia , lookup

X-linked severe combined immunodeficiency wikipedia , lookup

Polyclonal B cell response wikipedia , lookup

Psychoneuroimmunology wikipedia , lookup

Immunomics wikipedia , lookup

Transcript
THE DEVELOPMENT OF A MOUSE MUTANT FOR STUDYING THE ROLE OF NKG2D
IN VIVO
B. ZAFIROVA, R. ANTULOV, B. POLIĆ
Department of Histology and Embryology, Faculty of Medicine, University of Rijeka,
Rijeka, Croatia
SUMMARY
NKG2D is an activating receptor that is involved in the innate and adaptive immune
response to various forms of cellular stress (infections, heat shock, etc.) and tumour
transformation. In mice, it is expressed on NK, NKT and T (CD8+ activated and memory ab and
some gd) cells. NKG2D is a transmembrane type II glycoprotein, encoded by a gene situated
within the NK complex of the mouse chromosome 6, which binds different, mostly stressinduced MHC class I-like molecules (MULT-1, H60 and Rae 1 family) on wide variety of cell
types.
Although the role of NKG2D has been intensively investigated in different models (viral
infections, tumour immunosurveillance, autoimmunity, etc.), to address more specific questions
on the role of NKG2D in the development, homeostasis and effector functions of the immune
system the use of a genetic approach seems to be inevitable. Therefore, we have generated
NKG2D knock out mouse strain by targeting of NKG2D in Bruce 4 (C57BL/6) embryonic stem
(ES) cells. Following the selection and screening procedure, we have identified several ES cell
clones positive for the homologous recombination of the targeting vector. Upon the
microinjection of the clones we have obtained several chimeras that have given germ-line
transmission of the mutation.
Related documents
Gamma
Gamma
Gene Section KLRK1 (killer cell lectin-like receptor subfamily K, member 1)
Gene Section KLRK1 (killer cell lectin-like receptor subfamily K, member 1)
PE anti-mouse RAE-1δ Antibody
PE anti-mouse RAE-1δ Antibody
Gene Section KLRK1 (killer cell lectin-like receptor subfamily K, member 1)
Gene Section KLRK1 (killer cell lectin-like receptor subfamily K, member 1)
The Great Ball Game
The Great Ball Game
The DNA Damage Response Arouses the Immune System
The DNA Damage Response Arouses the Immune System
REFERENCES
REFERENCES
Iannello, A. and D. H. Raulet. 2014. Immunosurveillance of senescent cancer cells by natural killer cells. Oncoimmunology 3:e27616 
Iannello, A. and D. H. Raulet. 2014. Immunosurveillance of senescent cancer cells by natural killer cells. Oncoimmunology 3:e27616 
Cancer-Cells
Cancer-Cells
Diefenbach, A., and D.H. Raulet. 2003. Innate immune recognition by stimulatory immunoreceptors. Curr Opin Immunol 15:37-44.
Diefenbach, A., and D.H. Raulet. 2003. Innate immune recognition by stimulatory immunoreceptors. Curr Opin Immunol 15:37-44.
Gasser, S., S. Orsulic, E.J. Brown, and D.H. Raulet. 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436(7054):1186-1190.
Gasser, S., S. Orsulic, E.J. Brown, and D.H. Raulet. 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436(7054):1186-1190.
Lesson 6 7•5
Lesson 6 7•5
Clinical profile of hospitalized patients with acutely decompensated
Clinical profile of hospitalized patients with acutely decompensated
Diefenbach, A., J.K. Hsia, M.Y. Hsiung, and D.H. Raulet. 2003. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur J Immunol 33:381-391.
Diefenbach, A., J.K. Hsia, M.Y. Hsiung, and D.H. Raulet. 2003. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur J Immunol 33:381-391.
Ianello A, Raulet DH. 2013. Immune Surveillance of Unhealthy Cells by Natural Killer Cells. Cold Spring Harbor symposia on quantitative biology.
Ianello A, Raulet DH. 2013. Immune Surveillance of Unhealthy Cells by Natural Killer Cells. Cold Spring Harbor symposia on quantitative biology.
MATRNAL FETAL RELATIONSHIP AND THE Rh BLOODGROUP
MATRNAL FETAL RELATIONSHIP AND THE Rh BLOODGROUP
Raulet, D.H. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3:781-790.
Raulet, D.H. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3:781-790.
NKG2D DAP12 with Mouse, but Not Human, A Structural Basis for
NKG2D DAP12 with Mouse, but Not Human, A Structural Basis for
Impaired NK Cytotoxicity in Cancer Patients Down
Impaired NK Cytotoxicity in Cancer Patients Down
Differential Clinical Significance of Individual NKG2D Ligands in
Differential Clinical Significance of Individual NKG2D Ligands in
Pinto, A. K., A. M. Jamieson, D. H. Raulet, and A. B. Hill. 2007. The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40. J. Viro 81:12564-12571 .
Pinto, A. K., A. M. Jamieson, D. H. Raulet, and A. B. Hill. 2007. The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40. J. Viro 81:12564-12571 .
Animal cell lines
Animal cell lines